Risk of bacterial vaginosis, Trichomonas vaginalis and Candida albicans infection among new users of combined hormonal contraception vs LNG-IUS

Reproductive Health

A systematic review and meta-analysis of venous thrombosis risk among users of combined oral contraception

Int J Gynaecol Obstet.

Dragoman MV, Tepper NK, Fu R, Curtis KM, Chou R, Gaffield ME

doi: 10.1002/ijgo.12455.

HPV and Gynecologic CancerReproductive Health

Lifetime cancer risk and combined oral contraceptives: the Royal College of General Practitioners' Oral Contraception Study

Am J Obstet Gynecol.

Iversen L, Sivasubramaniam S, Lee AJ, Fielding S, Hannaford PC

doi: 10.1016/j.ajog.2017.02.002.

Sexually Transmitted Diseases (STD)

Specific vaginal bacteria are associated with increased risk of Trichomonas vaginalis acquisition in women

J Infect Dis.

Jarrett OD, Srinivasan S, Richardson BA, Fiedler T, Wallis JM, Kinuthia J, Jaoko W, Mandaliya K, Fredricks DN, McClelland RS

doi: 10.1093/infdis/jiz354.

Pregnancy and Childbirth

Trichomonas vaginalis in Pregnancy: Patterns and Predictors of Testing, Infection, and Treatment

Obstet Gynecol.

Kim TG, Young MR, Goggins ER, Williams RE, HogenEsch E, Workowski KA, Jamieson DJ, Haddad LB

doi: 10.1097/AOG.0000000000003776.

Hormonal contraceptives and risk of ischemic stroke in women with migraine: a consensus statement from the European Headache Federation (EHF) and the European Society of Contraception and Reproductive Health (ESC)

doi: 10.1186/s10194-017-0815-1.

Reproductive Health

Impact of estrogen type on cardiovascular safety of combined oral contraceptives

Contraception.

Dinger J, Do Minh T, Heinemann K

doi: 10.1016/

Drospirenone-Containing Oral Contraceptive Pills and the Risk of Venous Thromboembolism: An Assessment of Risk in First-Time Users and Restarters

Drug Saf.

Larivée N, Suissa S, Coulombe J, Tagalakis V, Filion KB

doi: 10.1007/s40264-017-0525-2.

Reproductive Health

Cycle control with an extended-regimen oral contraceptive combining levonorgestrel and ethinyl estradiol that includes continuous low-dose ethinyl estradiol instead of the traditional hormone-free interval

Int J Womens Health.

Nappi RE, Lobo Abascal P, Hsieh J, Micheletti MC

doi: 10.2147/IJWH.S142078.

First venous thromboembolism and hormonal contraceptives in young French women

Medicine (Baltimore).

Hugon-Rodin J, Horellou MH, Conard J, Flaujac C, Gompel A, Plu-Bureau G; and for the COntraception, REcurrent Venous Event (COREVE) investigators

doi: 10.1097/MD.

Related content

A systematic review and meta-analysis of venous thrombosis risk among users of combined oral contraception

Lifetime cancer risk and combined oral contraceptives: the Royal College of General Practitioners' Oral Contraception Study

Specific vaginal bacteria are associated with increased risk of Trichomonas vaginalis acquisition in women

Trichomonas vaginalis in Pregnancy: Patterns and Predictors of Testing, Infection, and Treatment

Hormonal contraceptives and risk of ischemic stroke in women with migraine: a consensus statement from the European Headache Federation (EHF) and the European Society of Contraception and Reproductive Health (ESC)

Impact of estrogen type on cardiovascular safety of combined oral contraceptives

Drospirenone-Containing Oral Contraceptive Pills and the Risk of Venous Thromboembolism: An Assessment of Risk in First-Time Users and Restarters

Cycle control with an extended-regimen oral contraceptive combining levonorgestrel and ethinyl estradiol that includes continuous low-dose ethinyl estradiol instead of the traditional hormone-free interval

First venous thromboembolism and hormonal contraceptives in young French women